ITMI20001051A0 - Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari - Google Patents

Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari

Info

Publication number
ITMI20001051A0
ITMI20001051A0 IT2000MI001051A ITMI20001051A ITMI20001051A0 IT MI20001051 A0 ITMI20001051 A0 IT MI20001051A0 IT 2000MI001051 A IT2000MI001051 A IT 2000MI001051A IT MI20001051 A ITMI20001051 A IT MI20001051A IT MI20001051 A0 ITMI20001051 A0 IT MI20001051A0
Authority
IT
Italy
Prior art keywords
treatment
formulations containing
bronchopulmonary diseases
glucocorticosteroid
drug
Prior art date
Application number
IT2000MI001051A
Other languages
English (en)
Inventor
David Lewis
Gaetano Brambilla
Brian Meakin
Alessandra Ferraris
David Garderton
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI20001051A0 publication Critical patent/ITMI20001051A0/it
Priority to IT2000MI001051A priority Critical patent/IT1318514B1/it
Priority to CZ20023717A priority patent/CZ20023717A3/cs
Priority to EEP200200632A priority patent/EE200200632A/xx
Priority to JP2001581828A priority patent/JP2004515454A/ja
Priority to US10/275,891 priority patent/US20030190289A1/en
Priority to PCT/EP2001/005211 priority patent/WO2001085174A1/en
Priority to EA200201059A priority patent/EA200201059A1/ru
Priority to HU0302036A priority patent/HUP0302036A2/hu
Priority to PL01366212A priority patent/PL366212A1/xx
Priority to CA002408647A priority patent/CA2408647A1/en
Priority to AU2001258395A priority patent/AU2001258395A1/en
Priority to EP01931690A priority patent/EP1280532A1/en
Priority to SK1606-2002A priority patent/SK16062002A3/sk
Priority to MXPA02011132A priority patent/MXPA02011132A/es
Priority to PE2001000418A priority patent/PE20011271A1/es
Priority to TNTNSN01071A priority patent/TNSN01071A1/fr
Priority to ARP010102254A priority patent/AR028448A1/es
Publication of ITMI20001051A1 publication Critical patent/ITMI20001051A1/it
Priority to MA26880A priority patent/MA26899A1/fr
Priority to BG107257A priority patent/BG107257A/xx
Priority to NO20025394A priority patent/NO20025394L/no
Priority to HR20020893A priority patent/HRP20020893A2/xx
Application granted granted Critical
Publication of IT1318514B1 publication Critical patent/IT1318514B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IT2000MI001051A 2000-05-12 2000-05-12 Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. IT1318514B1 (it)

Priority Applications (21)

Application Number Priority Date Filing Date Title
IT2000MI001051A IT1318514B1 (it) 2000-05-12 2000-05-12 Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2001258395A AU2001258395A1 (en) 2000-05-12 2001-05-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
SK1606-2002A SK16062002A3 (sk) 2000-05-12 2001-05-08 Farmaceutický prostriedok na použitie v aerosólovom inhalátore s odmeranou dávkou a spôsob jeho výroby
JP2001581828A JP2004515454A (ja) 2000-05-12 2001-05-08 気管支肺疾患の治療のためのグルココルチコイド薬物を含有する製剤
US10/275,891 US20030190289A1 (en) 2000-05-12 2001-05-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
PCT/EP2001/005211 WO2001085174A1 (en) 2000-05-12 2001-05-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
EA200201059A EA200201059A1 (ru) 2000-05-12 2001-05-08 Препараты, содержащие глюкокортикостероидное лекарственное средство, для лечения бронхолегочных заболеваний
HU0302036A HUP0302036A2 (hu) 2000-05-12 2001-05-08 Glükokortikoidot tartalmazó készítmény bronchopulmonális betegségek kezelésére
PL01366212A PL366212A1 (en) 2000-05-12 2001-05-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
CA002408647A CA2408647A1 (en) 2000-05-12 2001-05-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
CZ20023717A CZ20023717A3 (cs) 2000-05-12 2001-05-08 Farmaceutický prostředek
EP01931690A EP1280532A1 (en) 2000-05-12 2001-05-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
EEP200200632A EE200200632A (et) 2000-05-12 2001-05-08 Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
MXPA02011132A MXPA02011132A (es) 2000-05-12 2001-05-08 Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares.
PE2001000418A PE20011271A1 (es) 2000-05-12 2001-05-10 Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
TNTNSN01071A TNSN01071A1 (fr) 2000-05-12 2001-05-11 Formulations contenant un medicament glucocorticoide pour le traitement des maladies bronchopulmonaires
ARP010102254A AR028448A1 (es) 2000-05-12 2001-05-11 Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
MA26880A MA26899A1 (fr) 2000-05-12 2002-10-25 PREPARATIONS CONTENANT UN MEDICAMENT GLUCOCORTICOiDE POUR LE TRAITEMENT DES MALADIES BRONCHOPULMONAIRES.
BG107257A BG107257A (en) 2000-05-12 2002-11-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
NO20025394A NO20025394L (no) 2000-05-12 2002-11-11 Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmon¶re sykdommer
HR20020893A HRP20020893A2 (en) 2000-05-12 2002-11-11 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001051A IT1318514B1 (it) 2000-05-12 2000-05-12 Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.

Publications (3)

Publication Number Publication Date
ITMI20001051A0 true ITMI20001051A0 (it) 2000-05-12
ITMI20001051A1 ITMI20001051A1 (it) 2001-11-12
IT1318514B1 IT1318514B1 (it) 2003-08-27

Family

ID=11445031

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI001051A IT1318514B1 (it) 2000-05-12 2000-05-12 Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.

Country Status (21)

Country Link
US (1) US20030190289A1 (it)
EP (1) EP1280532A1 (it)
JP (1) JP2004515454A (it)
AR (1) AR028448A1 (it)
AU (1) AU2001258395A1 (it)
BG (1) BG107257A (it)
CA (1) CA2408647A1 (it)
CZ (1) CZ20023717A3 (it)
EA (1) EA200201059A1 (it)
EE (1) EE200200632A (it)
HR (1) HRP20020893A2 (it)
HU (1) HUP0302036A2 (it)
IT (1) IT1318514B1 (it)
MA (1) MA26899A1 (it)
MX (1) MXPA02011132A (it)
NO (1) NO20025394L (it)
PE (1) PE20011271A1 (it)
PL (1) PL366212A1 (it)
SK (1) SK16062002A3 (it)
TN (1) TNSN01071A1 (it)
WO (1) WO2001085174A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
DE60103527T2 (de) * 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
BR112013001119A2 (pt) * 2010-07-16 2016-05-24 Cipla Ltd composição farmacêutica, processo para fabricar uma composição farmacêutica, uso de r(+)budesonida e um broncodilatador, e método de profilaxia ou tratamento de uma doença respiratória, inflamatória ou obstrutiva das vias aéreas
US20160151275A1 (en) * 2014-06-16 2016-06-02 James Kevin Shurtleff Method and devices for manufacturing and delivering of aerosolized formulations

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
CZ282972B6 (cs) * 1991-08-29 1997-11-12 Broncho-Air Medizintechnik Ag Lékařský přístroj pro inhalování dávkovaných aerosolů
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
AU4066693A (en) * 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
DK0735884T3 (da) * 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
ES2276736T3 (es) * 1995-04-14 2007-07-01 Smithkline Beecham Corporation Inhalador medidor de dosis para propionato de flucticasona.
EP0820323B1 (en) * 1995-04-14 2003-09-24 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
SI0820279T1 (en) * 1995-04-14 2002-12-31 Smithkline Beecham Corporation Metered dose inhaler for albuterol
KR19980703850A (ko) * 1995-04-14 1998-12-05 그레이엄브레레톤 베클로메타손 디프로피오네이트용 계량 흡입기
JP2728057B2 (ja) * 1995-10-30 1998-03-18 日本電気株式会社 光ディスク用情報アクセス装置
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
WO2000006121A1 (de) * 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
CZ303154B6 (cs) * 1998-11-13 2012-05-09 Jagotec Ag Suchá prášková formulace k inhalaci obsahující stearát horecnatý
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
ATE363892T1 (de) * 1999-03-05 2007-06-15 Chiesi Farma Spa Verbesserte pulverformulierungen zur inhalation
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.

Also Published As

Publication number Publication date
EA200201059A1 (ru) 2003-04-24
AR028448A1 (es) 2003-05-07
NO20025394D0 (no) 2002-11-11
CZ20023717A3 (cs) 2003-04-16
AU2001258395A1 (en) 2001-11-20
CA2408647A1 (en) 2001-11-15
WO2001085174A1 (en) 2001-11-15
TNSN01071A1 (fr) 2005-11-10
MA26899A1 (fr) 2004-12-20
BG107257A (en) 2003-06-30
EE200200632A (et) 2004-04-15
IT1318514B1 (it) 2003-08-27
US20030190289A1 (en) 2003-10-09
MXPA02011132A (es) 2003-04-25
NO20025394L (no) 2003-01-13
HRP20020893A2 (en) 2004-02-29
EP1280532A1 (en) 2003-02-05
HUP0302036A2 (hu) 2003-09-29
JP2004515454A (ja) 2004-05-27
ITMI20001051A1 (it) 2001-11-12
PL366212A1 (en) 2005-01-24
SK16062002A3 (sk) 2003-04-01
PE20011271A1 (es) 2002-01-11

Similar Documents

Publication Publication Date Title
ITMI20000312A0 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva
CY2014019I2 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
CY2013020I2 (el) Η χρηση μιας ενωσης ινγκενανης για την κατασκευη ενος φαρμακου για την θεραπεια του καρκινου
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
PT1062962E (pt) Dispensador de farmaco do tipo inalador
ITMI20001051A0 (it) Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari
AU2002362774A1 (en) Cyclosporin analogs for the treatment of lung diseases
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
NO20014926D0 (no) Farmasöytiske forbindelser
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
NO20012976L (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
ITMI20020773A1 (it) Farmaci per il trattamento dell'artrite
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
NO20003799L (no) Innkorporering av kolesterol senkende midler i konfekt- dosisformer
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
SE0004827D0 (sv) Therapeutic compounds
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
AU2002348105A1 (en) Oral dosage forms for improving the bioavailability of therapeutic agents
AU2003214317A1 (en) Use of a novel class of drugs for the treatment of parasitic diseases
EP1451308A4 (en) THERAPEUTIC USE OF AZIRIDINO COMPOUNDS